IBU-TEC ADV.MATER. INH.ON/ DE000A0XYHT5 /
2024-05-06 12:04:07 PM | Chg. -0.150 | Volume | Bid2:01:10 PM | Ask2:32:18 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
12.500EUR | -1.19% | 4,659 Turnover: 57,685.700 |
12.400Bid Size: 392 | 13.050Ask Size: 629 | 49.6 mill.EUR | 0.00% | - |
GlobeNewswire
2:47 PM
Actelis Receives Order and Delivers Instant, Secure Fiber-Grade Networking to Modernize City of Bake...
GlobeNewswire
2:40 PM
AITX’s RAD Passes Production Savings onto Customers with Updated Pricing for RIO™ Solar-Powered Secu...
GlobeNewswire
2:30 PM
Live Ventures to Issue Fiscal Second Quarter 2024 Financial Results and Hold Earnings Conference Cal...
GlobeNewswire
2:30 PM
Hanmi Financial to Participate in the D.A. Davidson 26th Annual Financial Institutions Conference
GlobeNewswire
2:30 PM
CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9...
GlobeNewswire
2:30 PM
Nayax to Exhibit its Leading Payment and Vending Management Technology at The NAMA Show 2024
GlobeNewswire
2:30 PM
Ohmyhome Reports Robust Performance in the First Quarter of 2024, Anticipates Over 110% y-o-y Revenu...
GlobeNewswire
2:30 PM
Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
GlobeNewswire
2:30 PM
Latin Metals Receives Positive Results from Airborne Magnetic and Radiometric Survey, Organullo Proj...
GlobeNewswire
2:30 PM
Blüm Holdings Inc. Acknowledges Impact to Cannabis Industry from DEA’s Plan to Reschedule Marijuana
GlobeNewswire
2:30 PM
KULR Technology Group Regains Compliance with NYSE American Continued Listing Standards
GlobeNewswire
2:30 PM
Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor ...